Trials / Completed
CompletedNCT02427828
VRES Study in Two Phases to Monitor Cardiac Surgical Patients Following Discharge From ICU
Continuous, Ambulatory, Non Invasive, Vital Sign Monitoring Using VRES of Cardiac Surgical Patients Following Discharge From Intensive Care. Impact on Detection of Physiological Deterioration
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 208 (actual)
- Sponsor
- OBS Medical Ltd · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Failure to recognise deterioration early is a major cause of preventable deaths amongst hospital patients. The investigators wish to study whether continuous monitoring of 'vital signs' (pulse rate, breathing rate, and blood oxygen saturations) with computer modeled alerting to detect patient deteriorations can reduce cardiac arrest rate and critical care readmissions from the wards by alerting staff to clinical deteriorations more effectively than current paperbased systems. Continuous monitoring of 'vital signs' can be achieved in two ways. Continuous monitoring of 'vital signs' has traditionally been restricted to the bedside because of the need for the patient to be connected by wires to the monitor. More recently, advances in telemetry (wireless technology) have allowed the development of wearable devices which allow patients to mobilise freely, whilst constantly monitoring these 'vital signs'.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Visensia Respiration Rate Estimation Service (VRES) | Medical device product to provide respiration rate from PPG signal |
Timeline
- Start date
- 2013-03-01
- Primary completion
- 2014-06-01
- Completion
- 2014-07-01
- First posted
- 2015-04-28
- Last updated
- 2015-04-28
Locations
1 site across 1 country: United Kingdom
Source: ClinicalTrials.gov record NCT02427828. Inclusion in this directory is not an endorsement.